SynthesisBioscience reports2022

MicroRNA-21 as a diagnostic and prognostic biomarker of lung cancer: a systematic review and meta-analysis.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.